153 related articles for article (PubMed ID: 27714883)
21. Laminin inhibition of beta-amyloid protein (Abeta) fibrillogenesis and identification of an Abeta binding site localized to the globular domain repeats on the laminin a chain.
Castillo GM; Lukito W; Peskind E; Raskind M; Kirschner DA; Yee AG; Snow AD
J Neurosci Res; 2000 Nov; 62(3):451-62. PubMed ID: 11054814
[TBL] [Abstract][Full Text] [Related]
22. Dual effects of familial Alzheimer's disease mutations (D7H, D7N, and H6R) on amyloid β peptide: correlation dynamics and zinc binding.
Xu L; Chen Y; Wang X
Proteins; 2014 Dec; 82(12):3286-97. PubMed ID: 25137638
[TBL] [Abstract][Full Text] [Related]
23. Alzheimer's Amyloid-β Sequesters Caspase-3 in Vitro via Its C-Terminal Tail.
Chang YJ; Linh NH; Shih YH; Yu HM; Li MS; Chen YR
ACS Chem Neurosci; 2016 Aug; 7(8):1097-106. PubMed ID: 27227450
[TBL] [Abstract][Full Text] [Related]
24. Crystal structure of human cystatin C stabilized against amyloid formation.
Kolodziejczyk R; Michalska K; Hernandez-Santoyo A; Wahlbom M; Grubb A; Jaskolski M
FEBS J; 2010 Apr; 277(7):1726-37. PubMed ID: 20175878
[TBL] [Abstract][Full Text] [Related]
25. An enzyme-linked immunosorbent assay to compare the affinity of chemical compounds for β-amyloid peptide as a monomer.
Jiang C; Feng Y; Huang X; Xu Y; Zhang Y; Zhou N; Shen X; Chen K; Jiang H; Liu D
Anal Bioanal Chem; 2010 Mar; 396(5):1745-54. PubMed ID: 20135308
[TBL] [Abstract][Full Text] [Related]
26. Effect of antisense peptide binding on the dimerization of human cystatin C--gel electrophoresis and molecular modeling studies.
Stachowiak K; Rodziewicz-Motowidło S; Sosnowska R; Kasprzykowski F; Łankiewicz L; Grubb A; Grzonka Z
Acta Biochim Pol; 2004; 51(1):153-60. PubMed ID: 15094836
[TBL] [Abstract][Full Text] [Related]
27. Structural evolution and membrane interaction of the 40-residue β amyloid peptides: differences in the initial proximity between peptides and the membrane bilayer studied by solid-state nuclear magnetic resonance spectroscopy.
Qiang W; Akinlolu RD; Nam M; Shu N
Biochemistry; 2014 Dec; 53(48):7503-14. PubMed ID: 25397729
[TBL] [Abstract][Full Text] [Related]
28. Structural studies of the tethered N-terminus of the Alzheimer's disease amyloid-β peptide.
Nisbet RM; Nuttall SD; Robert R; Caine JM; Dolezal O; Hattarki M; Pearce LA; Davydova N; Masters CL; Varghese JN; Streltsov VA
Proteins; 2013 Oct; 81(10):1748-58. PubMed ID: 23609990
[TBL] [Abstract][Full Text] [Related]
29. Curcumin Binding to Beta Amyloid: A Computational Study.
Rao PP; Mohamed T; Teckwani K; Tin G
Chem Biol Drug Des; 2015 Oct; 86(4):813-20. PubMed ID: 25776887
[TBL] [Abstract][Full Text] [Related]
30. Molecular Mechanisms of Alzheimer's Biomarker FDDNP Binding to Aβ Amyloid Fibril.
Parikh ND; Klimov DK
J Phys Chem B; 2015 Sep; 119(35):11568-80. PubMed ID: 26237080
[TBL] [Abstract][Full Text] [Related]
31. Modulation of Abeta42 fibrillogenesis by glycosaminoglycan structure.
Valle-Delgado JJ; Alfonso-Prieto M; de Groot NS; Ventura S; Samitier J; Rovira C; Fernàndez-Busquets X
FASEB J; 2010 Nov; 24(11):4250-61. PubMed ID: 20585030
[TBL] [Abstract][Full Text] [Related]
32. Humoral immune response to fibrillar beta-amyloid peptide.
Miller DL; Currie JR; Mehta PD; Potempska A; Hwang YW; Wegiel J
Biochemistry; 2003 Oct; 42(40):11682-92. PubMed ID: 14529278
[TBL] [Abstract][Full Text] [Related]
33. Homology modeling, molecular docking and MD simulation studies to investigate role of cysteine protease from Xanthomonas campestris in degradation of Aβ peptide.
Dhanavade MJ; Jalkute CB; Barage SH; Sonawane KD
Comput Biol Med; 2013 Dec; 43(12):2063-70. PubMed ID: 24290922
[TBL] [Abstract][Full Text] [Related]
34. Spectrofluorimetric analysis of the interaction of amyloid peptides with neuronal nitric oxide synthase: implications in Alzheimer's disease.
Padayachee ER; Whiteley CG
Biochim Biophys Acta; 2011 Dec; 1810(12):1136-40. PubMed ID: 21930189
[TBL] [Abstract][Full Text] [Related]
35. Molecular Dynamics Study on the Inhibition Mechanisms of Drugs CQ1-3 for Alzheimer Amyloid-β40 Aggregation Induced by Cu(2.).
Dong M; Li H; Hu D; Zhao W; Zhu X; Ai H
ACS Chem Neurosci; 2016 May; 7(5):599-614. PubMed ID: 26871000
[TBL] [Abstract][Full Text] [Related]
36. Copper interaction with cystatin C: effects on protein structure and oligomerization.
Żygowska J; Orlikowska M; Zhukov I; Bal W; Szymańska A
FEBS J; 2024 May; 291(9):1974-1991. PubMed ID: 38349797
[TBL] [Abstract][Full Text] [Related]
37. Insights into the mechanism of cystatin C oligomer and amyloid formation and its interaction with β-amyloid.
Perlenfein TJ; Mehlhoff JD; Murphy RM
J Biol Chem; 2017 Jul; 292(27):11485-11498. PubMed ID: 28487367
[TBL] [Abstract][Full Text] [Related]
38. Characterization of Mn(II) ion binding to the amyloid-β peptide in Alzheimer's disease.
Wallin C; Kulkarni YS; Abelein A; Jarvet J; Liao Q; Strodel B; Olsson L; Luo J; Abrahams JP; Sholts SB; Roos PM; Kamerlin SC; Gräslund A; Wärmländer SK
J Trace Elem Med Biol; 2016 Dec; 38():183-193. PubMed ID: 27085215
[TBL] [Abstract][Full Text] [Related]
39. Cystatin C-cathepsin B axis regulates amyloid beta levels and associated neuronal deficits in an animal model of Alzheimer's disease.
Sun B; Zhou Y; Halabisky B; Lo I; Cho SH; Mueller-Steiner S; Devidze N; Wang X; Grubb A; Gan L
Neuron; 2008 Oct; 60(2):247-57. PubMed ID: 18957217
[TBL] [Abstract][Full Text] [Related]
40. Polymorphic fibril formation by residues 10-40 of the Alzheimer's beta-amyloid peptide.
Paravastu AK; Petkova AT; Tycko R
Biophys J; 2006 Jun; 90(12):4618-29. PubMed ID: 16565054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
